Fundz

Vale Biolabs has raised €164K from Venture Kick to advance its platform for studying brain diseases and potential treatments.

PRIVATENov 09, 2026

Amount Raised

€164,000

Round Type

Pre-Seed

BiotechnologyHealth CareArtificial Intelligence

Investors

Venture Kick

Description

Vale Biolabs has received €164,000 funding from Venture Kick to enhance its research into brain diseases. The company employs lab-grown human brain tissue and predictive AI for drug response analysis. This funding will aid in developing standardized human brain organoids for more effective treatment testing. The goal is to improve drug development processes and outcomes for neurological disorders.

Who to call at Vale Biolabs, and when

A new round usually means Vale Biolabs is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Vale Biolabs raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vale Biolabs, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vale Biolabs. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vale Biolabs

About

Vale Biolabs is a biotech startup focused on advancing brain disease research through the use of lab-grown human brain tissue, automation, and predictive AI. The company aims to improve the understanding of drug responses and support the development of new therapies for neurological disorders. By creating standardized human brain organoids, Vale Biolabs seeks to address challenges in drug development by providing more accurate models for testing therapies. Their technology has the potential to reduce development costs and accelerate the introduction of new treatments for neurological conditions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vale Biolabs raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Vale Biolabs's next move

See what Strategic adds

Vale Biolabs raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.